IP Library Granted Patent US 7,506,649
Granted Patent B2
US 7,506,649 · App. 11/811,339 · Granted Mar 24, 2009

Nasal devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,506,649
App. No.
11/811,339
Granted
Mar 24, 2009
Kind
B2
Abstract

Described herein are adhesive nasal devices. In particular, the adhesive nasal respiratory devices described herein are configured to be worn in communication with a subject's nasal cavity and may include a rim body having a passageway therethrough, an airflow resistor in communication with the passageway of the rim body, and a flexible, adhesive holdfast layer extending outward from the periphery of the rim body. The rim body region may be formed from multiple parts (e.g., a first and a second rim body region), and the airflow resistor may be secured between the parts forming the rim body. Methods of manufacturing and assembling these adhesive nasal devices are also described.

Claims (51)

1. A nasal device adapted to be secured in communication with a subject's nasal cavity, the device comprising:

a rim body having a passageway therethrough;

an airflow resistor in communication with the passageway of the rim body, wherein the airflow resistor is configured to inhibit airflow during expiration more than airflow during inspiration; and

a flexible, adhesive holdfast extending outward from the periphery of the rim body, the adhesive holdfast comprising a biocompatible adhesive; and

a protective cover configured to be removed from the adhesive holdfast to expose at least a portion of the biocompatible adhesive.

2. The adhesive nasal device of claim 1 , wherein the rim body comprises an outer rim body secured to an inner rim body.

3. The adhesive nasal device of claim 1 , wherein the airflow resistor is secured at least partially within the rim body.

4. The device of claim 1 , further comprising a second rim body having a second airflow passage therethrough and a second airflow resistor secured in communication with the second airflow passage.

5. The device of claim 4 , wherein the adhesive holdfast comprises a bridge between the first and second rim bodies.

6. The device of claim 1 , wherein the airflow resistor comprises a flap valve.

7. The device of claim 1 , further comprising a tab configured to be grasped by a subject applying the device.

8. The device of claim 1 , wherein the rim body is made of medical grade plastic.

9. The device of claim 8 , wherein the medical grade plastic is selected from the group consisting of: Acrylonitrile Butadiene Styrene (ABS), polypropylene, polyethylene, polyurethane, polycarbonate, and polyetheretherketone.

10. A nasal device adapted to be secured in communication with a subject's nasal cavity, the device comprising:

a first rim body;

a second rim body, wherein the first rim body is attached to the second rim body and the combined first and second rim bodies include an airflow passage therethrough;

an airflow resistor in communication with the airflow passage, wherein the airflow resistor is configured to inhibit airflow during expiration more than airflow during inspiration; and

an adhesive holdfast secured to the combined first and second rim bodies; wherein the adhesive holdfast comprises a biocompatible adhesive configured to secure the nasal device in communication with the subject's nasal cavity.

11. The device of claim 10 , wherein the airflow resistor is secured between the first and second rim bodies.

12. The device of claim 10 , wherein the first rim body is attached to the second rim body by a press fit.

13. The device of claim 10 , wherein the first rim body is attached to the second rim body by a weld.

14. The device of claim 13 , wherein the weld is an ultrasonic weld.

15. The device of claim 10 , further comprising a third rim body that is attached to a fourth rim body, wherein the combined third and fourth rim bodies include a second airflow passage therethrough and a second airflow resistor secured in communication with the second airflow passage.

16. The device of claim 15 , wherein the adhesive holdfast comprises a bridge between the combined first and second rim bodies and the combined third and fourth rim bodies.

17. The device of claim 10 , wherein the first rim body has a flanged rim.

18. The device of claim 10 , wherein the airflow resistor comprises a flap valve.

19. The device of claim 10 , wherein the adhesive holdfast comprises a flexible adhesive substrate.

20. The device of claim 10 , further comprising a protective cover configured to be removed from the adhesive substrate to expose at least a portion of the biocompatible adhesive.

21. The device of claim 10 , wherein the adhesive holdfast comprises an annular region having an opening through which the combined first and second rim body regions extend.

22. The device of claim 10 , wherein the adhesive holdfast region comprises a tab configured to be grasped by a subject applying the device.

23. The device of claim 10 , wherein the first and second rim bodies are made of medical grade plastic.

24. The device of claim 23 , wherein the medical grade plastic is selected from the group consisting of: Acrylonitrile Butadiene Styrene (ABS), polypropylene, polyethylene, polyurethane, polycarbonate, and polyetheretherketone.

25. The device of claim 10 , wherein the airflow resistor comprises a flap valve and the flap is made of silicone or thermoplastic urethane.

26. The device of claim 10 , wherein the adhesive holdfast comprises an adhesive substrate made of silicone, polyurethane or polyethylene.

27. The device of claim 10 , wherein the biocompatible adhesive is hydrocolloid or acrylic.

28. A method of treating a subject, the method comprising:

removing a protective cover from an adhesive holdfast region of a nasal device, wherein the nasal device comprises:

a rim body having a passageway therethrough,

an airflow resistor in communication with the passageway of the rim body, wherein the airflow resistor is configured to inhibit airflow during expiration more than airflow during inspiration, and

a flexible, adhesive holdfast extending outward from the periphery of the rim body; and

applying the adhesive nasal device to a subject's nasal cavity or to both nasal cavities.

29. A nasal device adapted to be secured in communication with a subject's nasal cavity, the device comprising:

a rim body having a passageway therethrough;

an airflow resistor in communication with the passageway of the rim body, wherein the airflow resistor is configured to inhibit airflow during expiration more than airflow during inspiration; and

a flexible, adhesive holdfast extending outward from the periphery of the rim body, the adhesive holdfast comprising a biocompatible adhesive.

30. The adhesive nasal device of claim 29 , wherein the rim body comprises an outer rim body secured to an inner rim body.

31. The adhesive nasal device of claim 29 , wherein the airflow resistor is secured at least partially within the rim body.

32. The device of claim 29 , further comprising a second rim body having a second airflow passage therethrough and a second airflow resistor secured in communication with the second airflow passage.

33. The device of claim 29 , wherein the airflow resistor comprises a flap valve.

34. The device of claim 29 , wherein the rim body is made of medical grade plastic.

35. The device of claim 34 , wherein the medical grade plastic is selected from the group consisting of: Acrylonitrile Butadiene Styrene (ABS), polypropylene, polyethylene, polyurethane, polycarbonate, and polyetheretherketone.

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 13, 2021
From: CERBERUS BUSINESS FINANCE, LLC
To: FOUNDATION CONSUMER HEALTHCARE, LLC (AS SUCCESSOR BY MERGER TO THERAVENT, INC.)
Reel/Frame 055301/0186 →
PATENT SECURITY AGREEMENT Recorded Feb 12, 2021
From: FOUNDATION CONSUMER HEALTHCARE, LLC
To: CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT
Reel/Frame 055297/0052 →
PATENT SECURITY AGREEMENT Recorded Nov 3, 2017
From: THERAVENT, INC.
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 044035/0575 →
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2017
From: NXT CAPITAL, LLC, AS AGENT
To: THERAVENT, INC.
Reel/Frame 044022/0361 →
SECURITY INTEREST Recorded Mar 30, 2017
From: THERAVENT, INC.
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 041794/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: VENTUS MEDICAL, INC.
To: VENTUS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS) LLC
Reel/Frame 030865/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: VENTUS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: THERAVENT, INC.
Reel/Frame 030865/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: DOSHI, RAJIV; LOOMAS, BRYAN; PIERCE, RYAN KENDALL; SATHER, ELLIOT; SANDOVAL, ARTHUR G.; SERVAITES, JEFFREY W.; LEBAS, SANDRINE; DURACK, MATTHEW
To: VENTUS MEDICAL, INC.
Reel/Frame 019813/0146 →